<DOC>
	<DOCNO>NCT02933645</DOCNO>
	<brief_summary>Recent research suggest intranasally administer insulin reach brain quickly without pass circulation evoke increased insulin sensitivity tissue glucose consumption insulin stimulation ( low-dose hyperinsulinemic , euglycemic clamp ) . It still know mechanism cause change tissue involve . In study , change tissue-specific insulin sensitivity glucose uptake investigate use glucose-analogue radiotracer ( [ 18F ] -fluorodeoxyglucose ) positron emission tomography ( PET ) image insulin stimulation . Ten healthy male study , receive nasal spray contain insulin placebo randomize order two separate day . After spray administration , glucose uptake skeletal muscle , liver , subcutaneous visceral adipose tissue , myocardium , intestine , brown adipose tissue brain assess PET image glucose uptake tissue analyze . Endogenous glucose production calculate facilitate measurement glucose radiotracer uptake tissue tracer loss urine . As skeletal muscle consumes glucose available , likely administration insulin spray result increase uptake tissue . Some increase glucose uptake might also see tissue type insulin spray versus placebo spray administration .</brief_summary>
	<brief_title>Effects Intranasal Insulin Administration Tissue Specific Insulin Sensitivity</brief_title>
	<detailed_description>The objective study investigate effect intranasally administer insulin versus placebo tissue specific glucose uptake key metabolic organ well endogenous glucose production . SAMPLE SIZE : A total ten ( n=10 ) healthy male plan include , study conduct cross-over design subject investigate twice , use intranasal insulin use intranasal placebo single-blinded randomize order . SCREENING VISIT/ELIGIBILITY : Main inclusion exclusion criterion evaluate screen visit . This visit include frequently-sampled 75 g oral glucose tolerance test well anthropometric measurement clinical examination . PET STUDY VISITS : On PET study day two cannula insert , one radial antecubital vein tracer injection infusion glucose insulin , another opposite radial antecubital vein blood sampling . The arm sample take kept warm obtain arterialized venous blood . The subject rest supine position PET/CT scanner bed study . HYPERINSULINEMIC EUGLYCEMIC CLAMP : Whole-body insulin sensitivity assess hyperinsulinemic euglycemic clamp prim insulin infusion rate 0.25 mU/kg/min . To maintain glucose level 5.0 mmol/l intravenous glucose infusion administer individually need maintain euglycemia . NASAL SPRAY ADMINISTRATION : After 30 minute intravenous insulin infusion , subject receive either 160 E human insulin placebo intranasally . The small amount insulin know absorbed circulation insulin nasal spray mimic placebo day . Therefore subject administer 2.5 mU/kg additional intravenous insulin 15 minute together placebo spray administration . LABORATORY SAMPLES : To verify comparable insulin level circulation study , serum insulin C-peptide level determine fast state , repeatedly throughout experiment . BLINDING : The clinician study nurse aware spray give , subject blind additional insulin infusion placebo day do manner subject remain blinded . The spray give randomized order . The randomization code generate statistician use SAS , version 9.3 Windows . The randomization block size four method permute block randomization . The randomization do 16 subject case discontinuation . HEART RATE VARIABILITY : Heart rate variability record evaluate change autonomous nervous system activity spray administration visit . Polar RS800CX heart rate monitor ( Polar Electro Ltd. , Kempele , Finland ) two electrode use . FDG-PET-IMAGING : 70 minute start clamp 40 minute application nasal spray positron emission tomography ( PET ) scanning start injection glucose-analogue tracer label positron-emitting fluorine-18 ( [ 18F ] -fluorodeoxyglucose , [ 18F ] -FDG ) . PET/CT , GE DiscoveryTM ST System ( General Electric Medical Systems , Milwaukee , WI , USA ) final resolution 3.75 mm PET image use . All data correct dead-time , decay measure photon attenuation . Dynamic PET-scans reconstruct iterative reconstruction method . Radiotracer [ 18F ] -FDG produce PET Centre radiochemistry laboratory . Plasma radioactivity measure automatic gamma counter medical technologist laboratory Turku PET Centre ( Wizard 1480 3 '' , Wallac , Turku , Finland ) . PET-IMAGE ANALYSIS : To determine tissue-specific glucose uptake insulin stimulation PET data , time-activity-curves tissue activity activity measure plasma scan analyse graphically define tracer 's fractional uptake ( Ki ) . To calculate glucose uptake rate ( report Âµmol/kg/min ) , Ki multiply plasma glucose level , divide constant account difference transport dephosphorylation rate D-glucose FDG ( lump constant , LC ) divide tissue specific gravity . Based previous study LC 1,2 skeletal muscle ; 1,0 heart liver ; 1,14 adipose tissue ; 1,1 intestine 0,8 brain . After PET/CT urine sample collect quantify endogenous glucose production ( EGP ) . This determine subtract urine loss glucose infusion rate rate glucose disappearance .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>1 . BMI 18,525 kg/m2 2 . Fasting plasma glucose less 6.1 mmol/l 3 . Normal 2hour oral glucose tolerance test ( OGTT ) 1 . Any chronic disease medication could affect glucose metabolism 2 . History anorexia nervosa bulimia 3 . Smoking tobacco , take snuff , use narcotic 4 . Abusive use alcohol 5 . Any condition opinion investigator could create hazard subject safety , endanger study procedure interfere interpretation study result</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Insulin</keyword>
	<keyword>Intranasal</keyword>
	<keyword>Glucose/metabolism</keyword>
	<keyword>Glucose homeostasis</keyword>
</DOC>